Clinical trial / 2011
Pomegranate extract reduced disease activity and oxidative stress in rheumatoid arthritis patients
In an open-label pilot study, eight patients with active rheumatoid arthritis consumed 10 ml per day of pomegranate extract for 12 weeks, with six completing the trial. Pomegranate intake significantly lowered the composite Disease Activity Index by 17% (P < 0.02) and tender joint count by 62% (P < 0.005). These changes were accompanied by reductions in serum oxidative status (P < 0.02) and an increase in HDL-associated paraoxonase 1 activity (P < 0.02).
- Study type
- Uncontrolled clinical trial
- Who was studied
- 8 patients with active rheumatoid arthritis (6 completed)
- What was measured
- Disease activity score, joint count, and serum oxidative stress markers
THE PAPER
Consumption of pomegranate decreases serum oxidative stress and reduces disease activity in patients with active rheumatoid arthritis: a pilot study.
Balbir-Gurman A, Fuhrman B, Braun-Moscovici Y, Markovits D, Aviram M. Isr Med Assoc J, 2011.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.